Ultragenyx Pharmaceutical Inc
LSE:0LIF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ultragenyx Pharmaceutical Inc
LSE:0LIF
|
US |
|
S
|
Swire Pacific Ltd
OTC:SWRBF
|
HK |
|
R
|
Ryohin Keikaku Co Ltd
OTC:RYKKY
|
JP |
|
W
|
Wheaton Precious Metals Corp
LSE:WPM
|
CA |
|
Swiss Re AG
SIX:SREN
|
CH |
|
F
|
Fujitsu Ltd
SWB:FUJ1
|
JP |
|
Alpha Services and Holdings SA
LSE:0RCS
|
GR |
|
WEX Inc
NYSE:WEX
|
US |
|
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
|
CL |
|
I
|
Ichikoh Industries Ltd
TSE:7244
|
JP |
|
S
|
Sumitomo Rubber Industries Ltd
SWB:108
|
JP |
|
Q
|
Qingdao Port International Co Ltd
XMUN:0QP
|
CN |
|
Monopar Therapeutics Inc
NASDAQ:MNPR
|
US |
|
W
|
Westrock Co
F:1WR
|
US |
|
C
|
Carnival Corp
SWB:CVC1
|
US |
|
B
|
Bridgestone Corp
XMUN:BGT
|
JP |
|
P
|
Pultegroup Inc
DUS:PU7
|
US |
|
E
|
EDP Renovaveis SA
SWB:EDW
|
ES |
|
P
|
Progressive Corp
F:PGV
|
US |
Wall St Price Targets
0LIF Price Targets Summary
Ultragenyx Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for 0LIF is 53.31 USD with a low forecast of 27.38 USD and a high forecast of 101.2 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0LIF's stock price target?
Price Target
53.31
USD
According to Wall Street analysts, the average 1-year price target for 0LIF is 53.31 USD with a low forecast of 27.38 USD and a high forecast of 101.2 USD.
What is the Revenue forecast for Ultragenyx Pharmaceutical Inc?
Projected CAGR
23%
The compound annual growth rate for Revenue over the next 8 years is 23%.
What is the Gross Profit forecast for Ultragenyx Pharmaceutical Inc?
Projected CAGR
23%
The compound annual growth rate for Gross Profit over the next 7 years is 23%.
